 Referring to the database that had been online, she has a 13% chance of relapse in the next five years, and with aggressive chemotherapy (X-linked agammaglobulinemia (XLA) platinum-based), this would be reduced to an 8% risk of relapse with a 5% benefit. 
Referring to the database that had been online , she has a 13 % chance of relapse in the next five years , and with aggressive chemotherapy ( X - linked agammaglobulinemia ( XLA ) platinum - based ) , this would be reduced to an 8 % risk of relapse with a 5 % benefit .